Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

13 trials with published results (8%)

Research Maturity

90 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.2%

8 terminated out of 154 trials

Success Rate

91.8%

+5.2% vs benchmark

Late-Stage Pipeline

9%

14 trials in Phase 3/4

Results Transparency

14%

13 of 90 completed with results

Key Signals

13 with results92% success

Data Visualizations

Phase Distribution

84Total
Not Applicable (50)
Early P 1 (2)
P 1 (12)
P 2 (6)
P 3 (9)
P 4 (5)

Trial Status

Completed90
Recruiting17
Unknown17
Not Yet Recruiting9
Terminated8
Active Not Recruiting7

Trial Success Rate

91.8%

Benchmark: 86.6%

Based on 90 completed trials

Clinical Trials (154)

Showing 20 of 20 trials
NCT07851922RecruitingPrimary

Validity and Reliability of the Figure-of-Eight Walking and Weight-Bearing Lunge Tests in Hemophilia

NCT07579585Not ApplicableCompleted

Effects of Photobiomodulation in Hemophilia Patients.

NCT03754790Phase 3CompletedPrimary

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

NCT03974113Phase 2CompletedPrimary

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07425327CompletedPrimary

Validity and Reliability of the Two-minute Step Test in Hemophilia

NCT05895032Not ApplicableCompletedPrimary

Trial of an Exercise Intervention for Children With Haemophilia

NCT07791836Not Yet Recruiting

Prevalence of Inhibitor Development in Hemophilia A Patients Receiving Coageight: A Multicenter Cross-sectional Observational Study

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT07285460Phase 3RecruitingPrimary

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT04398628Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT06922045Phase 3Active Not RecruitingPrimary

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

NCT07516730CompletedPrimary

Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults With Hemophilia and Hemophilic Arthropathy

NCT05695391Phase 3TerminatedPrimary

Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery

NCT06345833Early Phase 1WithdrawnPrimary

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

NCT07691437Not ApplicableCompleted

Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia Patients

NCT07682519Not ApplicableRecruitingPrimary

Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain

NCT07187661Not ApplicableCompletedPrimary

Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis

NCT04384341Not ApplicableCompletedPrimary

Haemophilia and Bone Loss - PHILEOS Study

NCT05202951Active Not Recruiting

Chronic Pain and Hemophilia

NCT06580340Not ApplicableCompletedPrimary

Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia

Scroll to load more

Research Network

Activity Timeline